Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars

Launched by ALEXANDRIA UNIVERSITY · Aug 27, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how effective microneedling combined with regular insulin is for treating atrophic scars—these are indented scars that can occur from injuries or surgery. The study aims to find out if using insulin during microneedling helps improve the appearance of these scars better than just microneedling alone. Researchers believe that insulin might enhance the healing process, but they want to compare it directly to microneedling without any additional treatments to see if there's a real difference.

To participate in this trial, you need to be between 12 and 60 years old and have atrophic scars that are fully healed. However, if you have a history of certain types of scars, have been treated for scars recently, are diabetic, pregnant, or have any active infections, you may not be eligible. If you join the study, you can expect to receive either microneedling with insulin or microneedling alone, and you'll help researchers learn more about the best ways to treat these types of scars.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients aged 12 to 60 years
• • 2. Atrophic scars (traumatic or surgical)
• • 3. Completely healed scars
• Exclusion Criteria:
• • 1. Patients with a tendency or history of hypertrophic or keloidal scars
• • 2. Patients who received treatment for their scar in the past 3 months
• • 3. Diabetic patients or those with a history of Dysglycemia
• • 4. Pregnant, or lactating females
• • 5. Patients with active infection at the site of scar
• • 6. Patients currently receiving isotretinoin treatment or in the past month